Ovation Science Inc. (OVATF)

USD 0.05

(20.5%)

Market Cap (In USD)

1.82 Million

Revenue (In USD)

61.93 Thousand

Net Income (In USD)

-813.14 Thousand

Avg. Volume

17.45 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.0101-0.04375
PE
-4.82
EPS
-0.01
Beta Value
0.259
ISIN
CA69016D1087
CUSIP
-
CIK
-
Shares
37844700.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Terry H. Howlett
Employee Count
-
Website
https://ovationscience.com
Ipo Date
2019-01-29
Details
Ovation Science Inc. engages in the production of cannabis or hemp products in Canada, the United States, and Mexico. The company's Invisicare is a patented drug delivery technology for use in topical and transdermal skin care products containing hemp seed oil and cannabis under the Ovation and BASKiN brands. It offers cannabidiol infused health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and hand sanitizers under the DermSafe name. The company holds sublicenses for cannabis based products; and Lighthouse for licensed dispensaries in the United States. Ovation Science Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.